Dynamic International Prognostic Scoring System scores pretransplant therapy

  • Slides: 8
Download presentation
Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome

Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis by Markus Ditschkowski, Ahmet H. Elmaagacli, Rudolf Trenschel, Tanja Gromke, Nina K. Steckel, Michael Koldehoff, and Dietrich W. Beelen haematol Volume 97(10): 1574 -1581 October 9, 2012 © 2012 by Ferrata Storti Foundation

Summary of characteristics describing the patients' profile, disease classification, treatments and transplantation modalities. Markus

Summary of characteristics describing the patients' profile, disease classification, treatments and transplantation modalities. Markus Ditschkowski et al. Haematologica 2012; 97: 15741581 © 2012 by Ferrata Storti Foundation

Comparative summary of patient characteristics in the untreated and pre-treated cohort. Markus Ditschkowski et

Comparative summary of patient characteristics in the untreated and pre-treated cohort. Markus Ditschkowski et al. Haematologica 2012; 97: 15741581 © 2012 by Ferrata Storti Foundation

Cumulative incidence of relapse in patients surviving more than 100 days after HSCT stratified

Cumulative incidence of relapse in patients surviving more than 100 days after HSCT stratified by chronic GVHD. Kaplan-Meier analysis was retrospectively conducted on 76 patients who underwent HSCT between 1994 and 2010. Markus Ditschkowski et al. Haematologica 2012; 97: 15741581 © 2012 by Ferrata Storti Foundation

Predicted overall survival of patients stratified by pre-transplant DIPSS score. Markus Ditschkowski et al.

Predicted overall survival of patients stratified by pre-transplant DIPSS score. Markus Ditschkowski et al. Haematologica 2012; 97: 15741581 © 2012 by Ferrata Storti Foundation

Predicted overall survival of patients stratified by pre-transplant pharmacotherapy. Markus Ditschkowski et al. Haematologica

Predicted overall survival of patients stratified by pre-transplant pharmacotherapy. Markus Ditschkowski et al. Haematologica 2012; 97: 15741581 © 2012 by Ferrata Storti Foundation

Predicted relapse-free survival for patients stratified by chronic GVHD in patients surviving more than

Predicted relapse-free survival for patients stratified by chronic GVHD in patients surviving more than 100 days after HSCT. Kaplan-Meier analysis was used to predict event-free survival in all 76 patients. Markus Ditschkowski et al. Haematologica 2012; 97: 15741581 © 2012 by Ferrata Storti Foundation

Proportional hazards general linear model analysis of overall and event-free survival. Markus Ditschkowski et

Proportional hazards general linear model analysis of overall and event-free survival. Markus Ditschkowski et al. Haematologica 2012; 97: 15741581 © 2012 by Ferrata Storti Foundation

Sum Scores Components Scores Chronic Scores Acute RejectionSum Scores Components Scores Chronic Scores Acute Rejection
Quick Score Scoring Guide Scoring 1 Scoring assignsQuick Score Scoring Guide Scoring 1 Scoring assigns
Revised International Prognostic Scoring System for Myelodysplastic SyndromesRevised International Prognostic Scoring System for Myelodysplastic Syndromes
GROUP THERAPY FAMILY THERAPY COUPLES THERAPY GROUP THERAPYGROUP THERAPY FAMILY THERAPY COUPLES THERAPY GROUP THERAPY
Standard Scores Standard scores or zscores measure theStandard Scores Standard scores or zscores measure the
Reporting Scores from NGSS Assessments Exploring Scores SubscoresReporting Scores from NGSS Assessments Exploring Scores Subscores
zScores Standardized Scores Standardizing scores With nonequivalent assessmentszScores Standardized Scores Standardizing scores With nonequivalent assessments